Viewing Study NCT04570891



Ignite Creation Date: 2024-05-06 @ 3:16 PM
Last Modification Date: 2024-10-26 @ 1:46 PM
Study NCT ID: NCT04570891
Status: RECRUITING
Last Update Posted: 2023-11-22
First Post: 2020-09-24

Brief Title: Ultrasound-guided FICB for Proximal Femoral Osteotomy in Pediatric Patients
Sponsor: Seoul National University Hospital
Organization: Seoul National University Hospital

Study Overview

Official Title: Ultrasound-guided Fascia Iliaca Compartment Block for Proximal Femoral Osteotomy in Pediatric Patients a Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This prospective randomized controlled trial aims to examine the effect of fascia iliaca compartment block on the postoperative pain and opioid consumption in pediatric patients 3y age 18y who will undergo orthopedics surgery proximal femoral osteotomy

Patients will be allocated to either the FICBFascia iliaca compartment block IV PCA group or the control group no block IV PCA Fascia iliaca compartment block will be performed using 025 ropivacaine 1mLkg MAX 30mL under ultrasound-guidance at the end of surgery

The total opioid consumption at 12 and 24 hours after the surgery and the pain score at 10 min after PACU admin 1624 hours after the surgery the total dose of additional rescue analgesia intravenous ketorolac or nalbuphine at 12 and 24 hours after the surgery will be recorded
Detailed Description: This prospective randomized controlled trial aims to examine the effect of fascia iliaca compartment block on postoperative pain and opioid consumption in pediatric patients 3y age 18y who will undergo orthopedics surgery proximal femoral osteotomy

Patients will be allocated to either the FICBFascia iliaca compartment block IV PCA group or the control group no block IV PCA Fascia iliaca compartment block will be performed using 025 ropivacaine 1mLkg MAX 30mL under ultrasound-guidance at the end of surgery

The total opioid consumption at 12 and 24 hours after the surgery and the pain score at 10 min after PACU admin 1624 hours after the surgery the total dose of additional rescue analgesia intravenous ketorolac or nalbuphine at 12 and 24 hours after the surgery will be recorded

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None